Sat04192014

Last updateFri, 18 Apr 2014 10am

Leading pharmaceutical manufacturer plans to strengthen presence in Missouri with renewed investment and new jobs, Gov. Nixon says

In becoming independent from parent company Covidien, Mallinckrodt plans to invest $2 million, create 150 jobs in expansion of Hazelwood facility  
HAZELWOOD, Mo. – Gov. Jay Nixon today praised plans by Mallinckrodt, a leading global provider of specialty pharmaceuticals, to strengthen its presence in Missouri. As part of its spinoff from former parent company Covidien, Mallinckrodt plans to invest $2 million in its U.S. headquarters in Hazelwood, creating 150 new jobs in the area.

Register to read more...

Comments (0)
Only registered users can write comments!